NCT00031759View on ClinicalTrials.gov

Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

July 31, 2004

Study Completion Date

February 28, 2010

Conditions
Cervical CancerPrecancerous Condition
Interventions
DRUG

imiquimod

PROCEDURE

Ablative or excisional therapy

Trial Locations (8)

32224

Mayo Clinic, Jacksonville

48106

CCOP - Michigan Cancer Research Consortium, Ann Arbor

55905

Mayo Clinic Cancer Center, Rochester

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

61801

CCOP - Carle Cancer Center, Urbana

96813

MBCCOP - Hawaii, Honolulu

85259-5404

CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale

67214-3882

CCOP - Wichita, Wichita

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00031759 - Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia | Biotech Hunter | Biotech Hunter